FDA Approves Nirogacestat Tablets for Rare Desmoid Tumors
The approval is the first for a systemic therapy to treat desmoid tumors, offering patients an alternative to surgery.
Source: hcplive.com
Stay updated with breaking news from Springworks Thereapeutics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The approval is the first for a systemic therapy to treat desmoid tumors, offering patients an alternative to surgery.